A randomised controlled trial, economic evaluation and qualitative study of supervised consumption in patients managed with opiate maintenance treatment (the Super-C study)

Completed

• Conditions: Substance misuse - opiate dependance; Opiate dependance; Mental and Behavioural Disorders

• Registration Number: ISRCTN61294249
• Lead Sponsor: Hertfordshire Partnership NHS Foundation Trust (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-02-05
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 256

Inclusion Criteria

1. Confirmed symptoms of opioid dependency (including toxicological investigations)
2. Electing for maintenance treatment (as opposed to other forms of management, e.g., detoxification) with either methadone or buprenorphine
3. Aged 16 years or older, either sex

Exclusion Criteria

1. Chronic injectors refusing oral therapy
2. Under 16 years
3. Hypersensitivity to both buprenorphine and methadone
4. Treatment with suboxone (as this is not routinely supervised)
5. Severe medical condition making treatment hazardous in the opinion of the treating physician
6. Incapacity to give informed consent
7. Maintenance treatment during last four weeks
8. Those patients deemed to definitely require supervised consumption at discretion of the treating physician (such as homeless, those with a drug-using partner not in treatment)
9. Those patients where supervised consumption of their agreed treatment can not be provided for reasons of geographical placement (e.g. no provision of supervised consumption in the local pharmacy)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Retention in treatment at three months.